Phenotypic and genetic analyses of the heterogeneous population present in the cold-adapted master donor strain: A/Leningrad/134/17/57 (H2N2)

Virus Research

Volumn 102, Issue 2, 2004, Pages 165-176

  Youil, R ^a   Kiseleva, I ^a,b   Kwan, W S ^a   Szymkowiak, C ^a   Toner, T J ^a   Su, Q ^a   Klimov, A ^c   Rudenko, L ^b   Shaw, A R ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Russian Federation)

^c NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

Author keywords

Cold adaptive influenza vaccine; Influenza A virus; Vero cells

Indexed keywords

VIRUS VACCINE;

ANIMAL CELL; ARTICLE; CELL CULTURE; CLONE; DONOR; EGG; FEASIBILITY STUDY; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC VARIABILITY; INFLUENZA VIRUS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; TEMPERATURE SENSITIVITY; VIRUS IDENTIFICATION; VIRUS STRAIN; WILD TYPE;

ADAPTATION, PHYSIOLOGICAL; AMINO ACID SUBSTITUTION; ANIMALS; CELL LINE; CERCOPITHECUS AETHIOPS; COLD; INFLUENZA A VIRUS; INFLUENZA A VIRUS, H2N2 SUBTYPE; INFLUENZA VACCINES; MUTATION, MISSENSE; OVUM; PHENOTYPE; PLAQUE ASSAY; SEQUENCE ANALYSIS, PROTEIN; TEMPERATURE; VARIATION (GENETICS); VERO CELLS; VIRAL PROTEINS; VIRUS CULTIVATION;

INFLUENZA A VIRUS; INFLUENZA VIRUS;

EID: 1842850948     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virusres.2004.01.026     Document Type: Article

References (38)

1. Alexandrova G.I., Smorodintsev A.A. Obtaining of an additionally attenuated vaccinating cryophilic influenza strain. Rev. Roum. Inframicrobiol. 2:1965;179-189.
2. Alymova I.V., Kodihalli S., Govorkova E.A., Fanget B., Gerdil C., Webster R.G. Immunogenicity and protective efficacy in mice of influenza B virus vaccines grown in mammalian cells or embryonated chicken eggs. J. Virol. 72:1998;4472-4477.
3. Azzi A., Bartolomei-Corsi O., Zakrzewska K., Corcoran T., Newman R., Robertson J.S., Yates P., Oxford J.S. The haemagglutinins of influenza A (H1N1) viruses kin the 'O' or 'D' phases exhibit biological and antigenic differences. Epidemiol. Infect. 111:1993;135-142.
4. Bruhl P., Kerschbaum A., Kistner O., Barrett N., Dorner F., Gerencer M. Humoral and cell-mediated immunity to Vero cell-derived influenza vaccine. Vaccine. 19:2001;1149-1158.
5. Bush R.M., Bender C.A., Subbarao K., Cox N.J., Fitch W.M. Predicting the evolution of Human influenza A. Science. 286:1999;1921-1925.
6. Fang R., Min Jou W., Huyleroeck D., Devos R., Fiers W. Complete structure of A/duck/Ukraine/63 influenza hemagluttinin gene: animal virus as progenitor of human H3 Hong Kong 1968 influenza hemagglutinin. Cell. 25:1981;315-325.
7. Ferguson N.M., Galvani A.P., Bush R.M. Ecological and immunological determinants of influenza evolution. Nature. 422:2003;428-433.
8. Gambaryan A.S., Marinina V.P., Tuzikov A.B., Bovin N.V., Rudneva I.A., Sinitsyn B.V., Shilov A.A., Matrosovich M.N. Effects of host-dependent glycosylation of hemagglutinin on receptor-binding properties of H1N1 human influenza A virus grown in MDCK cells and in embyonated eggs. Virology. 247:1998;170-177.
9. Gambaryan A.S., Robertson J.S., Matrosovich M.N. Effects of egg-adaptation on the receptor-binding properties of human influenza A and B viruses. Virology. 258:1999;232-239.
10. Ghendon Y.S., Klimov A.I., Alexandrova G.I., Polezhaev F.I. Analysis of genome composition and reactogenicity of recombinants of cold-adapted and virulent virus strains. J. Gen. Virol. 53:1981;215-224.
11. Ghendon Y.S., Polezhaev F.I., Lisovskaya K.V., Medvedeva T.E., Alexandrova G.I., Klimov A.I. Recombinant cold-adapted attenuated influenza A vaccines for use in children: molecular genetic analysis of the cold-adapted donor and recombinants. Infect. Immun. 44:1984;730-733.
12. Govorkova E.A., Kaverin N.V., Gubareva L.V., Meigner B., Webster R.G. Replication of influenza A viruses in a green maonkey kidney continuous cell line (Vero). J. Infect. Dis. 172:1995;250-253.
13. Govorkova E.A., Kodihalli S., Alymova I.V., Fanget B., Webster R.G. Growth and immunogenicity of influenza viruses cultivated in Vero or MDCK cells and in embryonated chicken eggs. Dev. Biol. Stand. 98:1999;39-51.
14. Govorkova E.A., Murti G., Meignier B., Taisne C.de., Webster R.G. African Green Monkey Kidney (Vero) cells provide an alternative host cell system for Influenza A and B viruses. J. Virol. 70:1996;5519-5524.
15. Halperin S.A., Smith B., Mabrouk T., Germain M., Trepanier P., Hassell T., Treanor J., Gauthier R., Mills E.L. Safety and immunogenicity of a trivalent, inactivated, mammalian cell culture-derived influenza vaccine in healthy adults, seniors, and children. Vaccine. 20:2002;1240-1247.
16. Hardy C.T., Young S.A., Webster R.G., Naeve C.W., Owen R.J. Egg fluid and cells of the chorioallantoic membran of embryonated chicken eggs can select different variants of influenza A (H3N2) viruses. Virology. 211:1995;302-306.
17. Ito T., Suzuki Y., Takada A., Kawamoto A., Otsuki K., Masuda H., Yamada M., Suzuki T., Kida H., Kawaoka Y. Differences in sialic acid-galactose linkages in the chicken egg amnion and allantois influence human influenza virus receptor specificity and variant selection. J. Virol. 71:1997;3357-3362.
18. Katz J.M., Naeve C.W., Webster R.G. Host cell-mediated variation in H3N2 influenza viruses. Virology. 156:1987;386-395.
19. Katz J.M., Wang M., Webster R.G. Direct sequencing of the HA gene of influenza (H3N2) virus in original clinical samples reveals sequence identity with mammalian cell-grown virus. J. Virol. 64:1990;1808-1811.
20. Katz J.M., Webster R.G. Efficacy of inactivated A virus (H3N2) vaccines grown in mammalian cells or embryonated eggs. J. Infect. Dis. 160:1989;191-197.
21. Katz J.M., Webster R.G. Amino acid sequence identity between the HA1 of influenza A (H3N2) viruses grown in mammalian and primary chick kidney cells. J. Gen. Virol. 73:1992;1159-1165.
22. Kaverin N.V., Webster R.G. Impairment of multi-cycle influenza virus growth in Vero (WHO) cells by loss of trypsin activity. J. Virol. 69:1995;2700-2703.
23. Kawaoka Y., Krauss S., Webster R.G. Avian-to-Human transmission of the PB1 gene of Influenza A viruses in the 1957 and the 1968 pandemics. J. Virol. 63:1989;4603-4608.
24. Kilbourne E.D., Smith C., Brett I., Pokorny B.A., Johansson B., Cox N. The total influenza vaccine failure of 1947 revisited: major intra-subtypic antigenic change can explain failure of vaccine in a post-World War II epidemic. Proc. Natl. Acad. Sci. U.S.A. 99:2002;10748-10752.
25. Kiseleva I., Su Q., Toner T.J., Szymkowiak C., Kwan W.-S., Rudenko L., Shaw A.R., Youil R. Cell based assay for the determination of temperature sensitive and cold-adapted phenotype of influenza viruses. J. Virol. Methods. 116:2004;71-78.
26. Kistner O., Barrett P.N., Mundt W., Reiter M., Schober-Bendixen S., Dorner F. Development of a mammalian cell (Vero) derived candidate influenza virus vaccine. Vaccine. 16:1998;960-968.
27. Klimov I.A., Cox N.J., Wagner V.Y., Rocha E., Alexandrova G.I., Kendal A.P. Sequence changes in the live attenuated, cold-adapted variants of influenza A/Leningrad/134/57 (H2N2) virus. Virology. 186:1992;795-797.
28. Lin Y.-P., Wharton S.A., Martin J., Skehel J.J., Wiley D.C., Steinhauer D.A. Adaptation of egg-grown and transfectant influenza viruses for growth in mammalian cells: selection of hemagglutinin mutants with elevated pH of membrane fusion. Virology. 233:1997;402-410.
29. Reed L., Muench H. A simple method of estimating fifty per cent endpoints. Am. J. Hyg. 27:1938;493-497.
30. Robertson J.S., Bootman J.S., Nicolson C., Major D., Robertson E.W., Wood L.M. The hemagglutinin of influenza B virus present in clinical material is a single species identical to that of mammalian cell-grown virus. Virology. 179:1990;35-40.
31. Roberston J.S., Naeve C.S., Webster R.G., Bootman J.S., Newman R., Schild G.C. Alterations in the hemagglutinin associated with adaptation of influenza B virus to growth in eggs. Virology. 143:1985;166-174.
32. Rocha E.P., Xu X., Hall H.E., Allen J.R., Regnery H.L., Cox N.J. Comparison of 10 influenza a (H1N1 and H3N2) haemagglutinin sequences obtained directly from clinical specimens to those of MDCK cell- and egg- grown viruses. J. Gen. Virol. 74:1993;2513-2518.
33. Romanova J., Katinger D., Ferko B., Voglauer R., Mochalova L., Bovin N., Lim W., Katinger H., Egorov A. Distinct host range of influenza H3N2 virus isolates in Vero and MDCK cells is determined by cell specific glycosylation pattern. Virology. 307:2003;90-97.
34. Scholtissek C. Molecular evolution of influenza viruses. Virus Genes. 11:1996;209-215.
35. Scholtissek C., Rohde W., von Hoyningen V., Rott R. On the origin of the human influenza virus subtypes H2N2 and H3N2. Virology. 87:1978;13-20.
36. Schweiger B., Zadow I., Heckler R. Antigenic drift and variability of influenza viruses. Med. Microbiol. Immunol. 191:2002;133-138.
37. Wang M., Katz J.M., Webster R.G. Extensive heterogeneity in the hemagglutinin of egg-grown influenza viruses from different patients. Virology. 171:1989;275-279.
38. Wood J.M., Oxford J.S., Dunleavy M., Newman R.W., Major D., Robertson J.S. Influenza A (H1N1) vaccines efficacy in animal models is influenced by two amino acid substitutions in the hemagglutinin molecule. Virology. 171:1989;214-221.